OPS-2071

Class: Quinolone

Spectrum of activity:	Gram-positive
Details of activity:	C. difficile infection
Institute where first reported:	Otsuka Pharmaceutical Co. Ltd.
Highest developmental phase:	Phase 2
Development status:	Active

Chemical structure(s):
Canonical SMILES:	CC1=C2C(=CC(=C1C3=CC(=C(N)N=C3)C#N)F)C(=O)C(=CN2C4CC4)C(=O)O
Isomeric SMILES:	CC1=C2C(=CC(=C1C3=CC(=C(N=C3)N)C#N)F)C(=O)C(=CN2C4CC4)C(=O)O
InChI:	InChI=1S/C20H15FN4O3/c1-9-16(11-4-10(6-22)19(23)24-7-11)15(21)5-13-17(9)25(12-2-3-12)8-14(18(13)26)20(27)28/h4-5,7-8,12H,2-3H2,1H3,(H2,23,24)(H,27,28)
InChI Key:	DTSKYQBTFHFYAZ-UHFFFAOYSA-N
Structure link:	https://pubchem.ncbi.nlm.nih.gov/compound/71289877

External links:
Guide to Pharmacology:	OPS-2071
Citation:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336415/